Results from Phase One Trials of Ebola Vaccine in Kenya Called Promising
Your browser doesn’t support HTML5
Initial results from Phase One trials of an experimental Ebola vaccine known as rVSV ZEBOV have shown that the vaccine is safe and generates an immune response against the deadly Ebola virus. Lenny Ruvaga has more from the town of Kilifi.